Records containing: Recurrent Malignant Female Reproductive System Neoplasm

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-27
A Randomized Trial of Neratinib, A Pan-ERBB Inhibitor, Alone or in Combination With Palbociclib, a CDK4/6 Inhibitor, in Patients With HER2+ Gynecologic Cancers and Other Solid Tumors: A ComboMATCH Treatment Trial
CLINICAL_TRIALS study record update · 2026-04-27
Molecular Analysis for Combination Therapy Choice (ComboMATCH)
CLINICAL_TRIALS study record update · 2026-04-24
A Randomized Trial of Neratinib, A Pan-ERBB Inhibitor, Alone or in Combination With Palbociclib, a CDK4/6 Inhibitor, in Patients With HER2+ Gynecologic Cancers and Other Solid Tumors: A ComboMATCH Treatment Trial
CLINICAL_TRIALS study record update · 2026-04-24
Molecular Analysis for Combination Therapy Choice (ComboMATCH)
CLINICAL_TRIALS study record update · 2026-03-20
Ex-Vivo Expanded Allogeneic NK Cells for the Treatment of Solid Tumors of Pediatric Origin in Children and Young Adults
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2026-03-13
Integration of Self-Hypnosis in an Enhanced Recovery After Surgery (ERAS) Program: A Prospective Randomized Trial
CLINICAL_TRIALS study record update · 2026-02-09
Brachytherapy With Durvalumab (MEDI4736) and Tremelimumab in Subjects With Platinum-Resistant or Refractory and Recurrent or Metastatic Gynecological Malignancies
CLINICAL_TRIALS study record update · 2025-05-22
Phase Ib Clinical Investigation of Intraperitoneal Ipilimumab and Nivolumab in Patients With Peritoneal Carcinomatosis Due to Gynecologic Cancers